Consolidation of fundraising instruments and guidance
Important notice: Fundraising and corporate finance documents are now lodged with ASIC through the ASIC Regulatory Portal. For more information, see How you lodge fundraising and corporate finance documents.
Applications for relief should also be submitted through the ASIC Regulatory Portal. Fees will apply to an application and details about payment options are provided in the portal. For more information see, how you apply for relief.
In March 2016 we consolidated 7 regulatory guides about disclosure documents into one new regulatory guide: Regulatory Guide 254 Offering securities under a disclosure document (RG 254).
We also moved our existing guidance in Superseded RG 213 Facilitating debt raising (SRG 213) – on the on-sale of quoted securities that are issued on the conversion of convertible notes issued to wholesale investors or otherwise without prospectus disclosure – into Regulatory Guide 173 Disclosure for on-sale of securities and other financial products (RG 173), and revoked SRG 213.
We also consolidated 26 sunsetting class orders into 13 new legislative instruments and repealed 5 class orders.
This page sets out cross-references to:
- those parts of our previous guidance that related to the subject matter of RG 254 and RG 173;
- superseded class orders that related to the subject matter of our new legislative instruments; and
- repealed class orders.
- RG 254 Offering securities under a disclosure document
- RG 173 Disclosure for on-sale of securities and other financial products
- Superseded class orders
- Repealed class orders
RG 254 Offering securities under a disclosure document
Section of RG 254 |
Topic of guidance |
Previous guidance |
---|---|---|
Section A |
Why we have disclosure document |
New guidance |
Section A |
When a disclosure document is required |
New guidance |
Section A |
The various types of disclosure documents |
New guidance |
Section A |
ASIC’s role |
New guidance |
Section A |
Scope of this guide and summary of topics covered |
New guidance |
Section A |
Other guidance issuers may need to consider |
New guidance |
Section B |
Prospectuses |
SRG 56 and new guidance |
Section B |
Short-form prospectuses |
New guidance |
Section C |
Rationale for transaction-specific disclosure |
RG 66 |
Section C |
When transaction-specific disclosure can be used |
RG 66 |
Section C |
Effect of suspensions from quotation and trading halts |
RG 66 |
Section C |
Content requirements for transaction-specific prospectus |
RG 66 |
Section C |
ASIC’s exclusion powers—section 713(6) |
RG 66 |
Section C |
Relief from enhanced disclosure provisions |
RG 66 |
Section C |
Individual relief to use a transaction-specific prospectus |
RG 66 |
Section D |
Rationale for offer information statements |
New guidance |
Section D |
Content requirements for offer information statements |
New guidance |
Section D |
Financial reports for offer information statements |
SRG 157 |
Section D |
Relief for financial reports prepared for offer information statements |
SRG 157 |
Section E |
Profile statements |
New guidance |
Section E |
Two-part simple corporate bonds prospectus |
New guidance and SRG 213 |
Section F |
How to lodge a disclosure document |
New guidance |
Section F |
Our approach to withdrawing an offer under a disclosure document |
New guidance |
Section F |
Changes to disclosure documents following lodgement |
SRG 23 and SRG 152 |
Section F |
Lodging electronic disclosure documents |
RG 107 |
Section F |
Application forms |
SRG 56 and SRG 152 |
Section F |
Relief for application forms |
SRG 56 and new guidance |
Section G |
Exposure period requirements |
SRG 152 and new guidance |
Section G |
Access to disclosure documents |
SRG 152 |
Section G |
What we will do to facilitate access to disclosure documents |
SRG 152 and new guidance |
Section G |
Where we will extend the exposure period |
SRG 152 |
Section G |
Relief from the exposure period |
SRG 152 |
Section G |
Applications for securities during the exposure period |
SRG 152 |
Section H |
When a supplementary or replacement disclosure document is required |
SRG 23 and new guidance |
Section H |
Form, content and procedure requirements |
SRG 23 and new guidance |
Section H |
Consequences of lodging a supplementary or replacement disclosure document |
New guidance |
Section H |
Relief to consolidate supplementary disclosure documents |
SRG 23 and new guidance |
Section I |
Quotation condition |
SRG 99 and new guidance |
Section I |
Minimum subscription condition |
RG 228 and new guidance |
Section I |
Relief for calculating time periods |
New guidance |
Section I |
Consequences of the minimum subscription condition and/or quotation condition not being satisfied |
New guidance |
Section I |
Relief to provide refresh documents |
New guidance |
Section J |
General prohibition on advertising and publicity |
SRG 158 |
Section J |
Relief for advertising and publicity |
SRG 158 |
Section J |
How we monitor compliance with the advertising prohibitions |
SRG 158 |
Section K |
Debenture prospectuses |
SRG 155 |
Section L |
Pre-lodgement review of disclosure documents |
SRG 152 and RG 228 |
Section L |
Post-lodgement review of disclosure documents |
SRG 152 and new guidance |
Section L |
What we look for when reviewing a disclosure document |
RG 228 |
Section L |
What we do when there are disclosure concerns |
RG 228 |
RG 173 Disclosure for on-sale of securities and other financial products
Section of RG 173 |
Topic of guidance |
Previous guidance |
---|---|---|
Section B |
Relief to facilitate offers of convertible notes made without prospectus disclosure |
SRG 213 |
Section B |
Relief for offers of bank hybrids |
New guidance |
Superseded class orders
Superseded class order |
New legislative instrument |
CP 239 proposal |
---|---|---|
[CO 00/168] Relief from exposure period: quoted securities |
ASIC Corporations (Exposure Period) Instrument 2016/74 |
C3 |
[CO 00/169] Relief from exposure period: supplementary and replacement prospectuses |
ASIC Corporations (Exposure Period) Instrument 2016/74 |
C3 |
[CO 00/172] Offer information statements: relief in relation to financial statements |
ASIC Corporations (Offer Information Statements) Instrument 2016/73 |
C5 |
[CO 00/173] Debenture prospectuses: incorporation of information on application forms |
ASIC Corporations (Debenture Prospectuses) Instrument 2016/75 |
C4 |
[CO 00/174] Debenture prospectuses: updating of interest rate and term information |
ASIC Corporations (Debenture Prospectuses) Instrument 2016/75 |
C4 |
[CO 00/175] Pre-prospectus roadshow presentations |
ASIC Corporations (Market Research and Roadshows) Instrument 2016/79 |
C8 |
[CO 00/176] Pre-prospectus market research |
ASIC Corporations (Market Research and Roadshows) Instrument 2016/79 |
C8 |
[CO 00/190] Substituting and consolidating supplementary disclosure documents |
ASIC Corporations (Substituted Supplementary Disclosure Documents) Instrument 2016/78 |
C7 |
[CO 00/195] Offer of convertible securities under s713 |
ASIC Corporations (Offers of Convertibles) Instrument 2016/83 |
C12 |
[CO 00/656] Announcements to securities exchanges about offers by subsidiaries of the listed body |
ASIC Corporations (Market Research and Roadshows) Instrument 2016/79 |
C8 |
[CO 00/843] Options over listed securities: exposure period relief |
ASIC Corporations (Exposure Period) Instrument 2016/74 |
C3 |
[CO 00/1092] Application form relief for bonus issues of options |
ASIC Corporations (Options: Bonus Issues) Instrument 2016/77 |
C6 |
[CO 01/1455] Continuously quoted securities |
ASIC Corporations (Disregarding Technical Relief) Instrument 2016/73 |
C2 |
[CO 02/138] Announcements to financial markets by holding companies about financial products other than securities |
ASIC Corporations (Market Research and Roadshows) Instrument 2016/79 |
C8 |
[CO 02/141] Experts: citing in Product Disclosure Statements |
ASIC Corporations (Consents to Statements) Instrument 2016/72 |
C1 |
[CO 02/143] Financial product market research |
ASIC Corporations (Market Research and Roadshows) Instrument 2016/79 |
C8 |
[CO 02/145] Relief from exposure period: managed investment products able to be traded on a licensed financial market |
ASIC Corporations (Exposure Period) Instrument 2016/74 |
C3 |
[CO 04/671] Disclosure for on-sale of securities and other financial products |
ASIC Corporations (Sale Offers That Do Not Need Disclosure) Instrument 2016/80 |
C9 |
[CO 04/672] Extension of on-sale exemption |
ASIC Corporations (Disregarding Technical Relief) Instrument 2016/73 |
C2 |
[CO 07/428] Consent to quote: Citing credit ratings, trading data and geological reports in disclosure documents and PDS |
ASIC Corporations (Consents to Statements) Instrument 2016/72 |
C1 |
[CO 07/429] Consent to quote: Citing credit ratings agencies, trading data and geological reports in takeovers |
ASIC Corporations (Consents to Statements) Instrument 2016/72 |
C1 |
[CO 07/571] Disclosure exemption for rights issues |
ASIC Corporations (Disregarding Technical Relief) Instrument 2016/73 |
C2 |
[CO 08/25] Sale offers within 12 months after controller sales |
ASIC Corporations (Sale Offers By Controllers) Instrument 2016/81 |
C10 |
[CO 08/35] Disclosure relief for rights issues |
ASIC Corporations (Non-Traditional Rights Issues) Instrument 2016/84 |
C13 |
[CO 10/322] On-sale for convertible notes issued to wholesale investors |
ASIC Corporations (Sale Offers: Securities Issued on Conversion of Convertible Notes) Instrument 2016/82 |
C11 |
[CO 13/523] Citation of experts and consent to quote |
ASIC Corporations (Consents to Statements) Instrument 2016/72 |
C1 |
Repealed class orders
Superseded class order |
CP 239 proposal |
---|---|
[CO 00/167] Relief from exposure period: profile statement |
D1 |
[CO 00/177] Fundraising exemption: NZ prospectuses |
D2 |
[CO 00/188] Solicitors mortgage investment companies |
D4 |
[CO 00/229] Solicitors mortgage investment companies |
D5 |
[CO 00/238] Dividend reinvestment plans |
D5 |